Wire · opportunities
Oracle, AstraZeneca Explore AI To Tackle Clinical-Trial Recruitment Challenge
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 21 October 2026 · Fusion42 review
Oracle and AstraZeneca announced a collaboration to use AI and real-world data to improve patient recruitment for clinical trials, aiming to identify eligible patients earlier and enhance clinical trial efficiency across various disease areas.
This Wire brief sits within Fusion42's coverage of AI Frontier Models, Biotech and Digital Health.
◆ ◆ The Wire takeaway
Clinical trial founders are facing fewer barriers to patient recruitment as Oracle and AstraZeneca integrate AI tools that could widen trial access and shorten patient identification times. Your trials can move faster, but plan now to adopt these emerging AI-driven workflows or risk falling behind.
◆ Coverage
1 source · 20 Oct 2026
◆ Related on Wire
◆ Topics